Registered entities
D&D Pharmatech Co., Ltd.
Reg. No. 120-88-21933South Korea
Innovation
17 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 557 times.
| Year | Filings |
|---|---|
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 3 |
Investor mix
12 investors on record; lead investors include Praxis Capital, Smile Gate Investment; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 42% |
| Private equity | 3 | 25% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 3 | 25% |